Rekord Newspaper
Journalist
1 minute read
24 Feb 2021
3:08 pm

WATCH: Don’t rush Covid-19 vaccine rollout, cautions Dr Imtiaz Sooliman

Rekord Newspaper

'I don’t think that’s impossible given the research capacity and skill in the scientific community,' says Sooliman.

Dr Imtiaz Sooliman. Picture: Gallo Images/Sunday Times/Thapelo Morebudi

He says that while 57% efficacy against the 501Y.V2 variant of the virus is a good start, more research is required.

“Several vaccines are being tested, and we may just get one that’s substantially more efficient against the South African strain of Covid-19. So, while 57% is a reasonable start, we may get something better.

ALSO READ: Health department gets green light from Sahpra to procure vaccine from India 

“I don’t think that’s impossible given the research capacity and skill in the scientific community,” says Sooliman.

South Africa’s vaccination programme against Covid-19 is underway after the arrival of the Johnson & Johnson vaccine replacing the AstraZeneca that was found to be inefficient against the South African strain of the virus.

According to Sooliman, a medical doctor, there are other important factors to give attention to while we are awaiting the right vaccine such as supplying oxygen to hospitals, clinics and ambulances.

ALSO READ: Johnson & Johnson vaccine moderately effective, less against SA Covid-19 variant

He says the shortage of oxygen at these places have led to the death of many patients. Journalist Izak du Plessis asked Sooliman to explain why he is so cautious against over-hyping and rushing the roll-out of the vaccine.

Watch the video

This article was republished from Rekord East with permission

For more news your way, download The Citizen’s app for iOS and Android.